References

Barnard N, Foster A. How to treat Pseudomonas otitis in dogs. Vet Rec.. 2018; 182:(4)109-10 https://doi.org/10.1136/vr.k413

Bartlett SJ, Rosenkrantz WS, Sanchez S. Bacterial contamination of commercial ear cleaners following routine home use. Vet Dermatol.. 2011; 22:(6)546-53 https://doi.org/10.1111/j.1365-3164.2011.00988.x

Bothwell MR, Smith AL, Phillips T. Recalcitrant otorrhea due to Pseudomonas biofilm. Otolaryngol Head Neck Surg.. 2003; 129:(5)599-601

Buckley LM, McEwan NA, Nuttall T. Tris-EDTA significantly enhances antibiotic efficacy against multidrug-resistant Pseudomonas aeruginosa in vitro. Vet Dermatol.. 2013; 24:(5)519-e122 https://doi.org/10.1111/vde.12071

Chan WY, Khazandi M, Hickey EE, Page SW, Trott DJ, Hill PB. In vitro antimicrobial activity of seven adjuvants against common pathogens associated with canine otitis externa. Vet Dermatol.. 2019; 30:(2)133-e38 https://doi.org/10.1111/vde.12712

Choe WT, Murray MT, Stidham KR, Roberson JB. N-Acetylcysteine as an adjunct for refractory ear infections. Otol Neurotol. 2007; 28:(8)1022-5

Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. Microbial biofilms. Annu Rev Microbiol.. 1995; 49:711-45

Dinicola S, De Grazia S, Carlomagno G, Pintucci JP. N-acetylcysteine as powerful molecule to destroy bacterial biofilms. A systematic review. Eur Rev Med Pharmacol Sci.. 2014; 18:(19)2942-8

Igarashi Y, Oka Y. Vestibular ototoxicity following intratympanic applications of chlorhexidine gluconate in the cat. Arch Otorhinolaryngol.. 1988; 245:(4)210-17

Igarashi Y, Suzuki J. Cochlear ototoxicity of chlorhexidine gluconate in cats. Arch Otorhinolaryngol.. 1985; 242:(2)167-76

Lundman L, Bagger-Sjöbäck D, Juhn SK, Morizono T. Pseudomonas aeruginosa exotoxin A and Haemophilus influenzae type b endotoxin. Effect on the inner ear and passage through the round window membrane of the chinchilla. Acta Otolaryngol Suppl.. 1992; 493:69-76

May ER, Conklin KA, Bemis DA. Antibacterial effect of N-acetylcysteine on common canine otitis externa isolates. Vet Dermatol.. 2016; 27:(3)188-e47 https://doi.org/10.1111/vde.12313

Metry CA, Maddox CW, Dirikolu L, Johnson YJ, Campbell KL. Determination of enrofloxacin stability and in vitro efficacy against Staphylococcus pseudintermedius and Pseudomonas aeruginosa in four ear cleaner solutions over a 28 day period. Vet Dermatol.. 2012; 23:(1)23-28 https://doi.org/10.1111/j.1365-3164.2011.00999.x

Mills PC, Ahlstrom L, Wilson WJ. Ototoxicity and tolerance assessment of a TrisEDTA and polyhexamethylene biguanide ear flush formulation in dogs. J Vet Pharmacol Ther.. 2005; 28:(4)391-7

Nuttall T, Cole LK. Ear cleaning: the UK and US perspective. Vet Dermatol.. 2004; 15:(2)127-36

Nuttall T, Cole LK. Evidence-based veterinary dermatology: a systematic review of interventions for treatment of Pseudomonas otitis in dogs. Vet Dermatol.. 2007; 18:(2)69-77

Paterson S. Pseudomonas otitis infection – Consultant on call.: NAVC Clinician's Brief; 2012

Paterson S. Brainstem auditory evoked responses in 37 dogs with otitis media before and after topical therapy. J Small Anim Pract.. 2018; 59:(1)10-15 https://doi.org/10.1111/jsap.12711

Paterson S, Matyskiewicz W. A study to evaluate the primary causes associated with Pseudomonas otitis in 60 dogs. J Small Anim Pract.. 2018; 59:(4)238-42 https://doi.org/10.1111/jsap.12813

Pye CC, Yu AA, Weese JS Evaluation of biofilm production by Pseudomonas aeruginosa from canine ears and the impact of biofilm on antimicrobial susceptibility in vitro. Vet Dermatol.. 2013; 24:(4)446-9 https://doi.org/10.1111/vde.12040

Robinson VH, Paterson S, Bennett C, Steen SI. Biofilm production of Pseudomonas spp. isolates from canine otitis in three different enrichment broths. Vet Dermatol.. 2019; https://doi.org/10.1111/vde.12738

Steen SI, Paterson S. The susceptibility of Pseudomonas spp. isolated from dogs with otitis to topical ear cleaners. J Small Anim Pract.. 2012; 53:(10)599-603 https://doi.org/10.1111/j.1748-5827.2012.01262.x

Wooley RE, Schall WD, Eagon RG, Scott TA. Efficacy of EDTA-trislysozyme lavage in the treatment of experimentally in induced Pseudomonas aeruginosa cystitis in the dog. Am J Vet Res.. 1974; 35:(1)27-9

Zhao T, Liu Y. N-acetylcysteine inhibit biofilms produced by Pseudomonas aeruginosa. BMC Microbiol.. 2010; 10 https://doi.org/10.1186/1471-2180-10-140

Pseudomonas otitis: what nurses need to know — frequently asked questions

02 May 2019
10 mins read
Volume 10 · Issue 4

Abstract

Ear disease is a common problem in primary care practice. A clear understanding of the underlying causes of disease, the need to recognise and treat infection effectively and reverse chronic change to the canal, are key to resolving disease and preventing recurrence. Although nurse's are not in a position to diagnose Pseudomonas infection in practice, it is important that they are aware of the aggressive, multiply resistant nature of the infection and the typical presenting signs of the disease. They can play an important role in the management of all otic disease but especially in Pseudomonas infection where owner compliance is often key to a successful outcome. Their input may be through a knowledge of taking and interpreting otic cytology or by giving advice to owners on the most effective way they can treat their pets through gentle cleaning and sympathetic choice of ear products.

The clinical management of otic infection with Pseudomonas spp. is challenging. The disease is painful and debilitating and the pathogen is commonly a multiple-resistant isolate. Infection often progresses to involve the middle ear, which makes selection of medication a difficult balance between the clinical benefits of the use of off-license drugs versus the potential damage caused by the use of ototoxic medication. This article on the management of Pseudomonas otitis has been written as a series of frequently asked questions, designed to help nurses understand and help in the management of this difficult disease.

Pseudomonas species are Gram-negative, rod-shaped bacteria. They are widespread in nature but are particularly found in aquatic habitats, soil and in decaying vegetation. Pseudomonas aeruginosa is the species most commonly implicated as a cause of otitis externa/media in the dog. It is recognised as an opportunistic pathogen (Paterson, 2012).

Pseudomonas is not a primary cause of otitis, but an infection that develops secondarily to the primary cause (Paterson and Matyskiewicz, 2018). Primary causes such as allergy, ectoparasites and endocrine disease are the inciting factors that lead to the development of otitis in both cats and dogs (Paterson and Matyskiewicz, 2018). They need to be addressed in all cases of otitis but especially in chronic disease where there is an increased risk of the development of multiple-resistant pathogens such as P. aeruginosa. Management of the underlying primary cause is essential to speed the resolution of the infection and prevent recurrence of infection, which is important to reduce antibiotic usage and reduce the risk of the development of more resistant forms of bacteria.

Register now to continue reading

Thank you for visiting The Veterinary Nurse and reading some of our peer-reviewed content for veterinary professionals. To continue reading this article, please register today.